Groowe / Newsroom / DSGN

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DSGN News

Design Therapeutics, Inc. Common Stock

Design Therapeutics to Participate in Upcoming Investor Conferences

globenewswire.com Nov 27, 2025 1:41 AM

Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results

globenewswire.com Nov 5, 2025 10:02 PM